Works matching IS 19414390 AND DT 2008 AND VI 1 AND IP 1

Results: 31

Making of a Phase III Study in Recurrent Ovarian Cancer: The Odyssey of GOG 213.

Published in:

Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 78, doi. 10.3816/COC.2008.n.009

By:

Coleman, Robert L.

Publication type:

Article

Maintenance therapy in epithelial ovarian cancer: rationale and results.

Published in:

2008

By:

Markman M

Publication type:

Journal Article

Debate: Patients with Any Stage I Ovarian Cancer Should Undergo Complete Surgical Resection Followed by Six Cycles of Adjuvant Carboplatin/Paclitaxel.

Published in:

Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 16

By:

Thigpen, J. Tate;
Kim, Kenneth H.;
Backes, Floor J.;
Copeland, Larry J.

Publication type:

Article

Debate: patients with any stage I ovarian cancer should undergo complete surgical resection followed by six cycles of adjuvant carboplatin/paclitaxel.

Published in:

2008

By:

Thigpen JT;
Kim KH;
Backes FJ;
Copeland LJ

Publication type:

Journal Article

A comparison of reimbursement for outpatient intraperitoneal chemotherapy versus intravenous therapy for ovarian cancer.

Published in:

2008

By:

Schink JC;
Hambleton CM;
Berry E;
Carson D;
Sherman TB;
Anastos LM

Publication type:

Journal Article

Making of a phase III study in recurrent ovarian cancer: the Odyssey of GOG 213.

Published in:

2008

By:

Coleman RL

Publication type:

Journal Article

Intraperitoneal chemotherapy for stage III ovarian cancer using the gynecologic oncology group protocol 172 intraperitoneal regimen: effect of supportive care using aprepitant and pegfilgrastim on treatment completion rate.

Published in:

2008

By:

Guile MW;
Horne AL;
Thompson SD;
Gardner GJ;
Giuntoli RL II;
Armstrong DK;
Bristow RE

Publication type:

Journal Article

Intraperitoneal chemotherapy: practicality versus theory.

Published in:

2008

By:

Spirtos NM

Publication type:

Journal Article

Investigating chemotherapy-induced nausea and vomiting.

Published in:

2008

By:

Plaxe SC

Publication type:

Journal Article

Results of an open-label study to evaluate the efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with carboplatin-containing chemotherapy in patients with ovarian cancer, primary peritoneal, or fallopian tube carcinoma (stage I-IV) or papillary serous cancer of the uterus.

Published in:

2008

By:

Timmins P III;
Kredentser D;
Hancock K;
Messing M;
Boehm KA;
Mull S;
Asmar L

Publication type:

Journal Article

HER2 overexpression/amplification and trastuzumab treatment in advanced ovarian cancer: a GINECO phase II study.

Published in:

2008

By:

Ray-Coquard I;
Guastalla JP;
Allouache D;
Combe M;
Weber B;
Cretin J;
Curé H;
Nunhuck S;
Paraiso D;
Mousseau M;
Pujade-Lauraine E;
GINECO, France

Publication type:

Journal Article

Erythropoiesis-stimulating agents and the practice of gynecologic oncology.

Published in:

2008

By:

Glaspy J

Publication type:

Journal Article

HER2 Overexpression/Amplification and Trastuzumab Treatment in Advanced Ovarian Cancer: A GINECO Phase II Study.

Published in:

Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 54, doi. 10.3816/COC.2008.n.005

By:

Ray-Coquard, Isabelle;
Guastalla, Jean Paul;
Allouache, Djelila;
Combe, Martin;
Weber, Béatrice;
Cretin, J.;
Curé, Hervé;
Nunhuck, S.;
Paraiso, Désiré;
Mousseau, Mireille;
Pujade-Lauraine, Eric

Publication type:

Article

Intraperitoneal Chemotherapy: The Standard or an Option?

Published in:

2008

By:

Thigpen, J. Tate

Publication type:

Editorial

Clinical indications for human papillomavirus vaccination.

Published in:

2008

By:

Herzog TJ;
Vallerie A;
Smith JS;
Wright JD

Publication type:

Journal Article

Debate: patients with recurrent ovarian cancer who experienced a clinical complete remission with initial platinum-based chemotherapy and had a treatment-free interval of at least six months before recurrence should receive platinum-based chemotherapy after any indicated surgery.

Published in:

2008

By:

Markman M;
Jiménez W;
Covens A

Publication type:

Journal Article

Debate: paclitaxel/doxorubicin/cisplatin is the best therapy for endometrial carcinoma.

Published in:

2008

By:

Temkin SM;
Powell MA

Publication type:

Journal Article

Debate: Paclitaxel/Doxorubicin/Cisplatin Is the Best Therapy for Endometrial Carcinoma.

Published in:

Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 30

By:

Temkin, Sarah M.;
Powell, Matthew A.

Publication type:

Article

Highlights from: the annual meeting of the Society of Gynecologic Oncologists: March 9-12, 2008; Tampa, FL.

Published in:

2008

By:

Ranganathan A

Publication type:

Journal Article

Intraperitoneal chemotherapy: the standard or an option?

Published in:

2008

By:

Thigpen JT

Publication type:

Journal Article

Highlights from: The Annual Meeting of the Society of Gynecologic Oncologists; March 9-12, 2008; Tampa, FL.

Published in:

Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 10, doi. 10.1016/S1941-4390(11)70036-8

By:

Ranganathan, Aarati;
Thigpen, J. Tate

Publication type:

Article

Debate: Patients with Recurrent Ovarian Cancer Who Experienced a Clinical Complete Remission with Initial Platinum-Based Chemotherapy and Had a Treatment-Free Interval of at Least Six Months Before Recurrence Should Receive Platinum-Based Chemotherapy After Any Indicated Surgery.

Published in:

Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 22

By:

Markman, Maurie;
Jiménez, Waldo;
Covens, Allen

Publication type:

Article

Clinical Indications for Human Papillomavirus Vaccination.

Published in:

Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 36, doi. 10.3816/COC.2008.n.002

By:

Herzog, Thomas J.;
Vallerie, Amy;
Smith, Jennifer S.;
Wright, Jason D.

Publication type:

Article

Erythropoiesis-Stimulating Agents and the Practice of Gynecologic Oncology.

Published in:

Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 44, doi. 10.3816/COC.2008.n.004

By:

Glaspy, John

Publication type:

Article

Intraperitoneal Chemotherapy for Stage III Ovarian Cancer Using the Gynecologic Oncology Group Protocol 172 Intraperitoneal Regimen: Effect of Supportive Care Using Aprepitant and Pegfilgrastim on Treatment Completion Rate.

Published in:

Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 68, doi. 10.3816/COC.2008.n.007

By:

Guile, Matthew W.;
Horne, Amy L.;
Thompson, Sharon D.;
Gardner, Ginger J.;
Giuntoli II, Robert L.;
Armstrong, Deborah K.;
Bristow, Robert E.

Publication type:

Article

A Comparison of Reimbursement for Outpatient Intraperitoneal Chemotherapy Versus Intravenous Therapy for Ovarian Cancer.

Published in:

Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 75, doi. 10.3816/COC.2008.n.008

By:

Schink, Julian C.;
Hambleton, Catherine M.;
Berry, Emily;
Carson, Doreine;
Sherman, Tammy Bamlett;
Anastos, Lisa M.

Publication type:

Article

Results of an Open-Label Study to Evaluate the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Carboplatin-Containing Chemotherapy in Patients with Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Carcinoma (Stage I-IV) or Papillary Serous Cancer of the Uterus

Published in:

Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 60, doi. 10.3816/COC.2008.n.006

By:

Timmins III, Patrick;
Kredentser, Daniel;
Hancock, Kenneth;
Messing, Mark;
Boehm, Kristi A.;
Mull, Stephanie;
Asmar, Lina

Publication type:

Article

Maintenance Therapy in Epithelial Ovarian Cancer: Rationale and Results.

Published in:

Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 40, doi. 10.3816/COC.2008.n.003

By:

Markman, Maurie

Publication type:

Article

Intraperitoneal Chemotherapy: Practicality Versus Theory.

Published in:

2008

By:

Spirtos, Nick M.

Publication type:

Opinion

Investigating Chemotherapy-Induced Nausea and Vomiting.

Published in:

2008

By:

Plaxe, Steven C.

Publication type:

Opinion

Clinical Ovarian Cancer.

Published in:

2008

By:

CIG Media Group

Publication type:

Table of Contents